Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by RazeKreationson Jun 25, 2021 6:19pm
182 Views
Post# 33454758

RE:Adlaid Capital Newsletter

RE:Adlaid Capital NewsletterI wonder how this is going to be spun from some so called analysts.
You look what some have posted on their websites and how gullible some people are.
They have graphs and outdated data that they spin with terminology like curves and double v and other gobbeldygook and totally ignore the facts of the business that Microbix is doing. Probably just plain laziness on some or really dont care about actual facts in order to gain an audience. Some are still claiming that MBX is overpriced and investors should sell.  It should be a crime how some take advantge of people and the spin they put out. It hurts many average people that count on investing to help support their pension plans.
There are many that are good but it only takes one rotten apple to spoil the whole box.
Hang onto your shares and acumalate more if you can.   Then you can laugh at these fools


Monday should be very interesting.


<< Previous
Bullboard Posts
Next >>